NCT02524444View on ClinicalTrials.gov

A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

142

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Malaria in Pregnant HIV + Patients
Interventions
DRUG

Mefloquine

Tabs Mefloquine 250mg

DRUG

Sulphadoxine-Pyrimethamine

Sulphadoxine 500mg , Pyrimethamine 25mg

Trial Locations (1)

200001

University College Hospital, Ibadan

All Listed Sponsors
collaborator

University of Ibadan

OTHER

lead

ORIYOMI OMOTOYOSI AKINYOTU

OTHER

NCT02524444 - A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients | Biotech Hunter | Biotech Hunter